First synthesis of oxa-analogous isoindigo-N-glycosides

Tetrahedron Letters

Volumn 49, Issue 2, 2008, Pages 289-291

  Libnow, Stefanie ^a   Hein, Martin ^a   Langer, Peter ^a,b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b LEIBNIZ INSTITUT FÜR KATALYSE E V AN DER UNIVERSITÄT ROSTOCK   (Germany)

Author keywords

2 Coumaranone; Aldol type condensation; Carbohydrates; Isoindigo analogues; N Glycosylisatines; Oxa analogous isoindigo N glycosides

Indexed keywords

2 COUMARANONE; GLYCOSIDE; ISOINDIGO N GLYCOSIDE; LACTONE DERIVATIVE; N GLYCOSYLISATINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DEPROTECTION REACTION; POLYMERIZATION; REACTION ANALYSIS; SYNTHESIS;

EID: 37149007307     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2007.11.057     Document Type: Article

References (23)

1. Review:. Gribble G., and Berthel S. Studies in Natural Products Chemistry Vol. 12 (1993), Elsevier Science, New York 365-409
2. Isolation of staurosporin:. Omura S., Iwai Y., Hirano A., Nakagawa A., Awaya J., Tsuchiya H., Takahashi Y., and Masuma R. J. Antibiot. 30 (1977) 275-282
3. Synthesis:. Link J.T., Raghavan S., Gallant M., Danishefsky S.J., Chou T.C., and Ballas L.M.J. Am. Chem. Soc. 118 (1996) 2825-2842
4. Pharmacological activity:. Yamashita Y., Fujii N., Murakata C., Ashizawa T., Okabe M., and Nakano H. Biochemistry 31 (1992) 12069-12075
5. Hein M., Michalik D., and Langer P. Synthesis 20 (2005) 3531-3534
6. Hein M., Nguyen T.B.P., Michalik D., Görls H., Lalk M., and Langer P. Tetrahedron Lett. 47 (2006) 5741-5745
7. Maskey R.P., Grün-Wollny I., Fiebig H.H., and Laatsch H. Angew. Chem. 114 (2002) 623-625
8. Angew. Chem., Int. Ed. 41 (2002) 597-599
9. Xiao Z., Hao Y., Liu B., and Qian L. Leukemia Lymphoma 43 (2002) 1763-1768
10. Beauchard A., Ferandin Y., Frere S., Lozach O., Blairvacq M., Meijer L., Thiery V., and Besson T. Bioorg. Med. Chem. 14 (2006) 6434-6443
11. Moon M.J., Lee S.K., Lee J.-W., Song W.K., Kim S.W., Kim J.I., Cho C., Choi S.J., and Kim Y.-C. Bioorg. Med. Chem. 14 (2006) 237-246
12. Libnow S., Hein H., Michalik D., and Langer P. Tetrahedron Lett. 47 (2006) 6907-6909
13. Sassatelli M., Saab E., Anizon F., Prudhomme M., and Moreau P. Tetrahedron Lett. 45 (2004) 4827-4830
14. Sassatelli M., Bouchikhi F., Messaoudi S., Anizon F., Debiton E., Barthomeuf C., Prudhomme M., and Moreau P. Eur. J. Med. Chem. 41 (2006) 88-100
15. Sassatelli M., Bouchikhi F., Aboab B., Anizon F., Doriano F., Prudhomme M., and Moreau P. Anti-Cancer Drugs 18 (2007) 1069-1074
16. Wang, L.; Liu, X.; Chen, R. U.S. Patent 6,566,341, 2003; Chem. Abstr. 138, 379213.
17. Wang, L.; Liu, X.; Chen, R. WO Patent 03051900, 2003; Chem. Abstr. 139, 47135.
18. Chavis C., De Gourcy C., Dumont F., and Imbach J.-L. Carbohydr. Res. 113 (1983) 1-20
19. Douglas J.G., and Honeyman J. J. Chem. Soc. (1955) 3674-3680
20. Preobrazhenskaya M.N., Yartseva I.V., and Ektova L.V. Nucleic Acid Chem. 2 (1978) 725-727
21. Yartseva I.V., Ektova L.V., and Preobrazhenskaya M.N. Bioorg. Khim. 1 (1975) 189-194
22. Similar conditions were previously employed for the aldol condensation of thiazolidinones with isatines:. Altuntas H., Ates O., Uydes-Dogan B.S., Alp F.I., Kaleli D., Özdemir O., Birteksöz S., Ötük G., Satana D., and Uzun M. Arzneim.-Forsch./Drug Res. 56 (2006) 239-248
23. 2Ph); 4.16 (m, 1H, H-2″); 3.83-3.72